CIK: 1817160 - Address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA 94158
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/30/24 19:06
7/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-7020.670-3-745D
7/30/24 19:06
7/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00092545D
4/30/24 18:33
4/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-2412.040-2-540D
4/30/24 18:33
4/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00051540D
1/30/24 18:52
1/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-197.990-2-636D
1/30/24 18:52
1/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00051736D
11/1/23 16:40
10/31/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-85.200-2-534D
11/1/23 16:40
10/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00051834D
8/1/23 16:26
7/31/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-189.650-2-630D
8/1/23 16:26
7/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00052130D
5/2/23 16:31
5/1/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-119.880-1-427D
5/2/23 16:31
4/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00031427D
2/1/23 16:15
1/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1711.780-1-623D
2/1/23 16:15
1/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00031623D
11/1/22 19:33
10/31/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1512.880-1-521D
11/1/22 19:33
10/30/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00031821D
8/2/22 17:45
8/1/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1915.670-1-619D
8/2/22 17:45
7/30/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00032019D
5/3/22 19:05
5/2/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1311.750-1-617D
5/3/22 19:05
4/30/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d00.00032317D
1/4/22 16:19
1/3/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScM.d179.06021514D
1/4/22 16:19
1/3/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-5328.960-2-1114D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact